City kids with asthma lose out on preventive treatment

A new study by specialists at the Johns Hopkins Children's Center and elsewhere suggests that only one in five inner-city children with chronic asthma gets enough medicine to control dangerous flare-ups of the disease.

The findings, reported in December’s Pediatrics, are disturbing, the researchers say, because preventive therapy failure leads to over-reliance on fast-acting “rescue” drugs after an asthma attack strikes and to more complications and increased risk of death.

The scientists interviewed parents of 180 Baltimore city children 2 to 9 years of age diagnosed with persistent asthma and studied pharmacy records. Overall, only 20 percent of the 180 got the recommended amount of daily controller medication, which is six or more refills in a 12-month period. Sixty percent of children got too little therapy to fully prevent flare-ups and 20 percent either got no medication at all or relied solely on quick-relief rescue drugs, which stop an asthma attack from progressing.

Current guidelines call for any child asthmatic with wheezing, coughing and shortness of breath two or more times a week or night-time symptoms two or more times a month to use inhaled corticosteroids as controller drugs to curb inflammation and prevent acute attacks.

“It’s clear that kids who need preventive drugs aren’t getting them,” says lead author Arlene Butz, Sc.D., R.N., asthma specialist at the Children’s Center. Previous research indicates that inner-city children are at special risk because their living conditions include other asthma triggers, such as exposure to secondhand smoke and mouse and cockroach allergens.

The survey also showed that children cared for by asthma specialists in or out of the hospital were more likely to follow a proper drug regimen than those who were not in these groups.

Butz and colleagues said training primary care pediatricians to check pharmacy records will help them monitor their patients’ adherence to the prescribed drug regimen.

Asthma is the country’s leading pediatric chronic illness, affecting 6.2 million children under the age of 18.

Source: Johns Hopkins Medical Institutions

Related stories:

Cells that mediate steroid-resistant asthma identified by scientists at Children's Hospital
Children's Hospital of Pittsburgh of UPMC researchers have identified cells that may play a key role in some forms of steroid-resistant asthma, a complication of the condition that makes treatment even more challenging.
Munich researchers discover key allergy gene
Together with colleagues from the Department of Dermatology and Allergy and the Center for Allergy and Environment of the Technische Universität München, scientists at the Helmholtz Zentrum München have pinpointed a major gene for allergic diseases. The gene was localized using cutting edge technologies for examining the whole human genome at the Helmholtz Zentrum München.
Note to pediatricians: Taper meds in kids with stable asthma
A study of how pediatricians prescribe asthma medications suggests that while most would readily increase a child's medication if needed, many are reluctant to taper off drug use when less might be best. A report on the study, led by Johns Hopkins Children's Center researchers, appears in the July issue of Pediatrics.
Asthma risk increases in children treated for HIV
Children whose immune systems rebound after treatment with potent anti-viral drugs for HIV infection face an increased risk of developing asthma, said a federally funded consortium of researchers led by those from Baylor College of Medicine in a report that appears online in the Journal of Allergy and Clinical Immunology.
Immune system kick-started in moist nasal lining in sinusitis, asthma and colds
Scientists at Johns Hopkins have outlined a new path for potential therapies to combat inflammation associated with sinusitis and asthma based on a new understanding of the body’s earliest immune response in the nose and sinus cavities.
Few studies consider the appropriate measurements for assessing clinical trials in children
Very few studies have asked what the appropriate measurements are for assessing treatments in clinical trials in children, according to a systematic review of paediatric clinical research conducted since 1950. The review by Ian Sinha and colleagues from the University of Liverpool, published in this week’s PLoS Medicine, also shows that few studies have involved parents and none have involved children in the process to select which measurements to use to assess clinical trials.
First do no harm? UH prof taking opposite approach to treat asthma
One month of tough breathing may help asthma sufferers breathe easier in the long run, according to research from one University of Houston professor.
Some moms quit cigarettes, marijuana, alcohol during pregnancy, but dads don't
Despite public health campaigns, a surprising number of women continue to use substances such as tobacco, marijuana and alcohol during pregnancy and their usage rebounds to pre-pregnancy levels within two years of having a baby, according to a new University of Washington study.

News discussion:

Medicine & Health news